{"name":"Rhodes Pharmaceuticals, L.P.","slug":"rhodes-pharmaceuticals-l-p","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Drug: PRC-063","genericName":"Drug: PRC-063","slug":"drug-prc-063","indication":"Attention-deficit/hyperactivity disorder (ADHD) in children and adults","status":"phase_3"},{"name":"PRC-063","genericName":"PRC-063","slug":"prc-063","indication":"Attention-deficit/hyperactivity disorder (ADHD) in children and adults","status":"phase_3"},{"name":"Aptensio XR","genericName":"Aptensio XR","slug":"aptensio-xr","indication":"Attention-deficit/hyperactivity disorder (ADHD) in children and adults","status":"marketed"}]}],"pipeline":[{"name":"Drug: PRC-063","genericName":"Drug: PRC-063","slug":"drug-prc-063","phase":"phase_3","mechanism":"PRC-063 is an extended-release formulation of methylphenidate designed to provide sustained dopamine and norepinephrine reuptake inhibition for ADHD symptom management.","indications":["Attention-deficit/hyperactivity disorder (ADHD) in children and adults"],"catalyst":""},{"name":"PRC-063","genericName":"PRC-063","slug":"prc-063","phase":"phase_3","mechanism":"PRC-063 is an extended-release formulation of methylphenidate that provides sustained dopamine and norepinephrine reuptake inhibition for ADHD symptom management.","indications":["Attention-deficit/hyperactivity disorder (ADHD) in children and adults"],"catalyst":""},{"name":"Aptensio XR","genericName":"Aptensio XR","slug":"aptensio-xr","phase":"marketed","mechanism":"Aptensio XR is an extended-release formulation of methylphenidate that increases dopamine and norepinephrine activity in the central nervous system to improve attention and reduce hyperactivity.","indications":["Attention-deficit/hyperactivity disorder (ADHD) in children and adults"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNb3YyUVNGQnJ3STNueFFXSWVaYmZYZW40NTFxczBCRGtNMDN0NTBwelpTRWhyZVlKUWlGTmxEQ1JEWlJka09Td1JreGdSbTgzWnlNbGRMZHVhenRualo2MDdQZmk1WnA3cmliZzdYajRjVWVDTGVoalBzMTREaGhUSkJxTGtFaVBoTkVOYXF3aVI?oc=5","date":"2024-12-30","type":"pipeline","source":"Association for Accessible Medicines","summary":"AAM Announces 2022 Board of Directors - Association for Accessible Medicines","headline":"AAM Announces 2022 Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE9oV3FZWEJoQ1ZPMkZVMERianVSZmFqNmNTN3VKcDBFN0lYUWlFY1NydGIwRjR1ZVFGNkZpT2ZxamZmZHJiMU9TX19wbERsMFpqTmFvX2R0aHI?oc=5","date":"2022-10-31","type":"pipeline","source":"Texas Medical Association","summary":"Nationwide Adderall Shortage Expected to Last Through 2022 - Texas Medical Association","headline":"Nationwide Adderall Shortage Expected to Last Through 2022","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBrUFBJU0RLa1FvZldVY1piUjl3UThzMjZ5OFRrU0p4VWVBYzlIeXpBVHlqWk5XWVFWTUQ5S0JPZ0ZQd2F5MkdZendZUlF5RnN5OW02TlU2VHdscTdLRktIQXkyVHZEbHc?oc=5","date":"2022-10-19","type":"pipeline","source":"Verywell Health","summary":"Adderall Shortage: What to Do If Your ADHD Medications Are Unavailable - Verywell Health","headline":"Adderall Shortage: What to Do If Your ADHD Medications Are Unavailable","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNUXZuemhxVFRzOUE2RU03bXV3Mzc2dHZYNExHZXBlN2RhZnVydTg4R2xRM0JObzFaWnBWOTlibktENzdRSHlRak81TDhaRXRRM2FPTzRvalJjU3YzdTZPcnVBNmdleGRkSzd2MmxJOG1tUXNwY0Vzam5BbktEdHVIbjZ1M0ZCYVpET0ZuWHExRjk1cmNtam9DWGxZTkRUSjU0TkFyYzZFTE1POUhX?oc=5","date":"2022-10-04","type":"pipeline","source":"Go Local Prov","summary":"RI Cities and Towns Sue McKinsey — Allege RICO in “Opioid Marketing Enterprise” - Go Local Prov","headline":"RI Cities and Towns Sue McKinsey — Allege RICO in “Opioid Marketing Enterprise”","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNWmRNX1VwaEdmZWh5UmgyTTNYZkUyQ2FLbGh3XzczRWhvdVctejRsMF8ya3JfOTZrRGNlSHFOeFR6S2M4WkRIMTVJb2FmS05yNFB0X1RhZzBISjVhNVpSbnhBb3RlNXFEYjAwX2dubFUxc2YtbUJGb2VKR1J2U1FEZVVQS2ZSRE5CdXhRWGItdFB4UHljX01Xd2FibkhlTUFhVWVCeGhsbl93V2h0UFE?oc=5","date":"2022-08-26","type":"pipeline","source":"Bloomberg.com","summary":"Adderall Shortages Spread to Four Pharmaceutical Companies - Bloomberg.com","headline":"Adderall Shortages Spread to Four Pharmaceutical Companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNZWNieW1YV1ZQZkx0akpuN0JpdUNfWWd1V1VtU1JyX2lnZHpHTkV6S3dpa19wdmFCSGp4aTJfY1h1cE9QTW5tZU1Pc3R3ZnNrZXVVNGZMb0ZTMEprOHN5SHRpQzhZUVlhdU1UM1VRcVhhcW1QbjdZdi1XY0VfZ3NJdlVEaXVfVHZQV1k0SDFTang2SmlDNkgtNGlpVjVGTXBRaDlzWUFib3lQQnhDM0tv?oc=5","date":"2022-07-07","type":"deal","source":"The Business Journals","summary":"Chinese biotech firm buys Coventry pharmaceutical plant - The Business Journals","headline":"Chinese biotech firm buys Coventry pharmaceutical plant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPckEtbEhmRnFtdkFoN2d4dm85eVpDdmxRRGVRTi1xX0l3S0Y5SF96Rk13TnQ5emo5MWlrXzgtVTJCb0xjVHUyd1BSRmREdlJIY0dCWUloY0ZjVkozNmJYbFd4enI4SE96d0FnSVZKT2Q1Y0sxcEJKQVRiNFJDdmtuMzk4akRqVWxF0gGQAUFVX3lxTFBFZWctOXdZeVIxMVR2Tk92dW1PVGRZUHpubWMwQm5neElyN29yLVFJYW5NVmk4cjdHeFBpTTNRTXdrT21yS2V0QlZNR2xZdTl4cTB6cDk3VjFnQXVEdEk0S1JPMEpWTjhSdDF0cGFKUVdXRThYbGZfTXRWZGs2ZlJ4cWpyQUsyMWNia1Z3dThKeg?oc=5","date":"2022-05-25","type":"deal","source":"pbn.com","summary":"China-based pharmaceutical company to acquire former Rhodes site - pbn.com","headline":"China-based pharmaceutical company to acquire former Rhodes site","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE1kQVBQNHNGN3JOVlktR3V4LVJrX1pVeTBieUZiU0VsTTI4SVY2djVoWDVQcURHcjhtS2c4NE9YNTlVdE5KOVFDdWRzRjN1d2w3eG9OZzlRbDk5bVczeDE3dzM2TnY1Y1BON2FJRkdRYmtzeVdIMXJvNXFKd284ZHc?oc=5","date":"2019-07-01","type":"pipeline","source":"The Colorado Sun","summary":"Colorado expands lawsuit against opioid-maker Purdue Pharma to include its owners, the Sackler family - The Colorado Sun","headline":"Colorado expands lawsuit against opioid-maker Purdue Pharma to include its owners, the Sackler family","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOYWFYRDVOa0VZeUVIazFuQnl4dHRveWJKVkFXWjJHcWdBX0dCLS1KOTg1YVcwMGdsMzdWcTlXNzZHZVFwMFY1cF9CVUJZWFJCUkdSV1hYVXFoUVExOFBwY0NuV3JKakJTQW1tYjRybkthLUtaUU5UdTBkbmF6eU1wOExtMmI1bWR4SUlhTWhKeXBKcUN3SURWQzl4Sk41cFgwUmR2el94Qnk1Vm94S0dwcUxVUzlfMkgtdzV5eA?oc=5","date":"2019-02-07","type":"pipeline","source":"BioSpace","summary":"Artist/Activist Domenic Esposito Places 800 lb Opioid Spoon Sculpture At Rhodes Pharmaceuticals - BioSpace","headline":"Artist/Activist Domenic Esposito Places 800 lb Opioid Spoon Sculpture At Rhodes Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOeWdrcVNmQ3RvVHh1WDJBTHE4aUY0QlowNTBpYjc4Z0N0UE5kR0czeDRJUjIyYkdwdmNtMVJQQ2dJdVVHVlJ0LXdoVVA0WWdNYlJmSnd1cVRIMDIzYzlVbkxuelRxcHN1ZEpVY1VKRGNQVnBPQkU5Z3lfSUhEWTNYZi1QajVLRWR1Tzl0ZlVLOG11MnVpUU0xbTVkVHl6S29OTUJWQ2pnOHNQMHQ4NF8zNUUxM0tMaEFCM0xzZ1FENWdVa3FicFpveXdB?oc=5","date":"2018-09-28","type":"patent","source":"NPR","summary":"Drugmakers Play The Patent Game To Lock In Prices, Block Competitors - NPR","headline":"Drugmakers Play The Patent Game To Lock In Prices, Block Competitors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPVDAyS19HaTVuZFdtczlfVjh1QVBXemdnTDRBbExub08zZmNRbmZxMnpsOGMwMUQ2ak04bGYyWnpucVdZZWVYOWd6a3RNaWp5UEV5YTVtVms0aEF3NnJQZFNiSWUtRlVZajAyRS1aVHBfTEVKT3ozTnQ5Yzh2ejFNSzNuNUtJU1Z2WFlrcVNpb9IBlwFBVV95cUxOT2t0X2E5OGtrRnlKNjF2YkZ2aElaWVRXWFFSelJoN29fN2FjS3h1b3VEMHpqX3JXcTlQUUd5R3BjeWhwVUpvUFV0U3pGVHpSSUhKNGIwY0pFam1NZ2pGalY0bEdtVHFWWEpmaGp3bG5SOVlFN0E3SUJPenBqZ2plMzZuZklKdDRNRWVIVC1FVmY5RWlxQ0NR?oc=5","date":"2018-09-11","type":"patent","source":"Artnet News","summary":"‘This Is Reprehensible’: Nan Goldin Responds to News That Richard Sackler Has Patented an OxyContin-Addiction Drug - Artnet News","headline":"‘This Is Reprehensible’: Nan Goldin Responds to News That Richard Sackler Has Patented an OxyContin-Addiction Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1FWk1Zb0pWR0c4TnFIcy10OUVFVkNaNG1DdW40Wng2dmdqdDhLeTBpNkpnUlhhTXBiNEthNW9LSDZpN2JONjNSMlQ1M1AwNG95VFloQW5KTk1SSEdpV1JUejhKZUd1ZmlYLTNCVnFsMlkwVDF0X2tFN2RUZw?oc=5","date":"2018-09-09","type":"pipeline","source":"Newsweek","summary":"Sackler Family Secretly Owns a Second Drug Company - Newsweek","headline":"Sackler Family Secretly Owns a Second Drug Company","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":2,"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}